{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:36:09Z","timestamp":1791916569653,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015688","name":"Queensland Eye Institute Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015170","name":"Department of Industry, Science and Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022217","name":"Flinders Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.oret.2023.08.012","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T20:42:33Z","timestamp":1693255353000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Sofia","family":"Androudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atitaya","family":"Apivatthakakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan K.","family":"Berkenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Phaik","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janejit","family":"Choovuthayakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa E.","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Farrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Gehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese K.","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Gozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Hern\u00e1ndez-Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared E.","family":"Knickelbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paradee","family":"Kunavisarut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndell L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Lee","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lloren\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"L\u00f3pez-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Mart\u00ednez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick F.","family":"O'Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kessara","family":"Pathanapitoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.B.","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhum","family":"Silpa-Archa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanthila","family":"Waduthantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travers R.E.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keryn L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Joon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Younan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2023.08.012_bib1","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.3390\/cancers13163921","article-title":"Vitreoretinal lymphoma","volume":"13","author":"Sobolewska","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.oret.2023.08.012_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.oret.2023.08.012_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaophthalmol.2017.3286","article-title":"Association of disease location and treatment with survival in diffuse large B-cell lymphoma of the eye and ocular adnexal region","volume":"135","author":"Ahmed","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib4","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1111\/aos.15284","article-title":"Incidence and survival of ocular diffuse large B-cell lymphomas","volume":"101","author":"Farrall","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.05.002","article-title":"Neoplasia and intraocular inflammation: from masquerade syndromes to immunotherapy-induced uveitis","volume":"72","author":"Touhami","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2023.08.012_bib6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.oret.2023.08.012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101053","article-title":"Challenges in the diagnosis and management of vitreoretinal lymphoma \u2013 clinical and basic approaches","volume":"90","author":"Takase","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2023.08.012_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.survophthal.2021.03.004","article-title":"Primary central nervous system lymphoma \u2013 ocular variant: an interdisciplinary review on management","volume":"66","author":"Raval","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.survophthal.2020.02.001","article-title":"Eye involvement in primary central nervous system lymphoma","volume":"65","author":"Farrall","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/bjh.17451","article-title":"Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma \u2013 20 years of experience","volume":"194","author":"Habot-Wilner","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.oret.2023.08.012_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jamaophthalmol.2014.4755","article-title":"Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study","volume":"133","author":"Riemens","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41433-021-01887-2","article-title":"Vitreoretinal lymphoma: central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration","volume":"37","author":"Dalvin","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2023.08.012_bib13","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.3390\/cancers13215372","article-title":"Update on novel therapeutics for primary CNS lymphoma","volume":"13","author":"Schaff","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.oret.2023.08.012_bib14","article-title":"The role of radiotherapy in newly diagnosed primary CNS lymphoma: A descriptive review and a pragmatic approach to clinical practice","volume":"39","author":"Manickam Gurusamy","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.oret.2023.08.012_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/cancers15020526","article-title":"Diagnosis and treatment using autologous stem-cell transplantation in primary central nervous system lymphoma: a systematic review","volume":"15","author":"Steffanoni","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.oret.2023.08.012_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjophthalmol-2013-304043","article-title":"Use of intravitreal rituximab for treatment of vitreoretinal lymphoma","volume":"98","author":"Larkin","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/bjh.14025","article-title":"How we diagnose and treat vitreoretinal lymphoma","volume":"173","author":"Fend","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.oret.2023.08.012_bib18","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence \u2013 what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2023.08.012_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060701","article-title":"The International Vitreoretinal B-Cell Lymphoma Registry: a protocol paper","volume":"12","author":"Smith","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.oret.2023.08.012_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2023.08.012_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oret.2023.08.012_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/IAE.0000000000002485","article-title":"Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration","volume":"40","author":"Nguyen","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.08.012_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081042","article-title":"Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences","volume":"8","author":"Finger","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.oret.2023.08.012_bib25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/jamaophthalmol.2020.3989","article-title":"Lifetime outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration","volume":"138","author":"Finger","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/IAE.0000000000002855","article-title":"Association of vitreoretinal lymphoma with systemic lymphoma","volume":"41","author":"Mashayekhi","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.08.012_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamaophthalmol.2013.334","article-title":"Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma","volume":"131","author":"Salomao","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib28","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2023.08.012_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.8.1.9","article-title":"Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference","volume":"8","author":"Smith","year":"2019","journal-title":"Trans Vis Sci Tech"},{"key":"10.1016\/j.oret.2023.08.012_bib30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/ceo.13304","article-title":"Emerging diagnostic tests for vitreoretinal lymphoma: a review","volume":"46","author":"Dawson","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","article-title":"Consensus recommendations for the diagnosis of vitreoretinal lymphoma","volume":"29","author":"Carbonell","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2023.08.012_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ophtha.2012.09.053","article-title":"Diagnostic criteria for primary ocular lymphoma","volume":"120","author":"Arcinue","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.08.012_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/IAE.0000000000002157","article-title":"Interleukins in the diagnosis of intraocular lymphoma: do we still need histologic confirmation?","volume":"38","author":"Dunn","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.08.012_bib34","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jamaophthalmol.2018.2887","article-title":"Potential diagnosis of vitreoretinal lymphoma by detection of MYD88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction","volume":"136","author":"Hiemcke-Jiwa","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.oret.2022.08.005","article-title":"Aqueous humor-derived MYD88 L265P mutation analysis in vitreoretinal lymphoma: a potential less invasive method for diagnosis and treatment response assessment","volume":"7","author":"Demirci","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.08.012_bib36","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.18632\/oncotarget.14008","article-title":"Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies","volume":"8","author":"Cani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.oret.2023.08.012_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajo.2021.11.023","article-title":"Advanced OCT analysis of biopsy-proven vitreoretinal lymphoma","volume":"238","author":"Pichi","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jha2.303","article-title":"Primary central nervous system lymphoma: inter-compartmental progression","volume":"3","author":"Raval","year":"2022","journal-title":"EJHaem"},{"key":"10.1016\/j.oret.2023.08.012_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ceo.13668","article-title":"Intraocular chemotherapy for vitreoretinal lymphoma: a review","volume":"48","author":"Kvopka","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib40","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41433-021-01657-0","article-title":"A\u00a0proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma","volume":"36","author":"Zhou","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2023.08.012_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10428194.2013.819576","article-title":"Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone","volume":"55","author":"Teckie","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oret.2023.08.012_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.oret.2019.05.021","article-title":"Tumor control and visual acuity outcomes in vitreoretinal lymphoma with and without sub-retinal pigment epithelium infiltration: analysis of 125 eyes of 70 patients at a single ocular oncology center","volume":"3","author":"Dalvin","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.08.012_bib43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaophthalmol.2017.1810","article-title":"Intravitreal melphalan for treatment of primary vitreoretinal lymphoma: a new indication for an old drug","volume":"135","author":"Shields","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.08.012_bib44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2023.08.012_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12913-016-1534-z","article-title":"Regional differences in recommended cancer treatment for the elderly","volume":"16","author":"Ho","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.oret.2023.08.012_bib46","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ophtha.2018.12.030","article-title":"Clinical registries in ophthalmology","volume":"126","author":"Tan","year":"2019","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023004153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023004153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:32:25Z","timestamp":1762853545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653023004153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2468653023004153"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2023.08.012","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2023.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}